Ready Capital Equity Method Investments increased by 3.6% to $167.25M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.1%, from $170.92M to $167.25M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 15.2% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $86.99M | $125.55M | $141.15M | $149.48M | $224.22M | $119.27M | $118.64M | $114.17M | $122.50M | $136.11M | $133.32M | $132.73M | $134.60M | $146.40M | $161.56M | $170.92M | $169.37M | $178.84M | $161.42M | $167.25M |
| QoQ Change | — | +44.3% | +12.4% | +5.9% | +50.0% | -46.8% | -0.5% | -3.8% | +7.3% | +11.1% | -2.1% | -0.4% | +1.4% | +8.8% | +10.4% | +5.8% | -0.9% | +5.6% | -9.7% | +3.6% |
| YoY Change | — | — | — | — | +157.7% | -5.0% | -15.9% | -23.6% | -45.4% | +14.1% | +12.4% | +16.3% | +9.9% | +7.6% | +21.2% | +28.8% | +25.8% | +22.2% | -0.1% | -2.1% |